Abstract
It is important to identify, assess and address current barriers to implementation of post approval changes that are intended to ensure continued (un-interrupted) operations, drive innovation and continual improvement in a maximally efficient, agile, flexible Pharmaceutical manufacturing sector. Leveraging ICH Q10 provides regulatory relief when it comes to addressing changes related to excipients, specifically excipient supplier′s name and address changes which will ensure and sustainable reliable global supply and availability of high quality product to patients through the entire commercial lifecycle of a product without extensive regulatory oversight.
- ICH Q10
- Pharmaceutical Quality System (PQS)
- Post Approval Change (PAC)
- Quality Risk Management (QRM)
- Regulatory relief
- Supplier name change
- Received December 10, 2019.
- Accepted February 14, 2020.
- Copyright © 2020, Parenteral Drug Association
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.